Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of osilodrostat in pediatric Cushing's disease
2018-001522-25Phase 2Unknown
- Sponsor
- Recordati SpA
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of osilodrostat in Corticotropin adenoma (ACTHoma), sponsored by Recordati SpA. Primary endpoint: Pharmacokinetic parameters of osilodrostat. Status: unknown.
02
Drugs
osilodrostat
03
Conditions
Corticotropin adenoma (ACTHoma)
Beyond the preview
Go deeper on 2018-001522-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001522-25.